Wockhardt informs about press release

01 Apr 2025 Evaluate
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed that it enclosed Press Release ‘Paediatric US Cancer Patient with Recalcitrant Blood and Liver Infection Successfully Treated with Zaynich™ (Zidebactam/Cefepime, WCK 5222)’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1357.75 7.40 (0.55%)
22-Jan-2026 14:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.20
Dr. Reddys Lab 1218.60
Cipla 1375.50
Zydus Lifesciences 884.70
Lupin 2165.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×